血小板丰富血在糖尿病中再生潜力
T I Vlasova1, E P Brodovskaya2, K S Madonov2
1Ogarev National Research Mordovian State University, Saransk, Russia. v.t.i@bk.ru.
概括
来自1型糖尿病患者的富血小板血 (PRP) 在体外显示再生潜力降低. 糖尿病PRP表现出较低的细胞增殖和增加的毒性,影响纤维细胞培养.
科学领域:
- 再生医学是一种再生医学.
- 细胞生物学 细胞生物学
- 糖尿病研究研究 糖尿病研究
背景情况:
- 富于血小板的血 (PRP) 用于其再生性质.
- 糖尿病 (DM) 可以影响细胞功能和伤口愈合.
- 第1型糖尿病对PRP疗效的影响需要进一步研究.
研究的目的:
- 评估从1型DM患者中PRP的体外再生潜力.
- 为了比较糖尿病PRP对人类皮肤纤维细胞的影响与非糖尿病对照.
- 评估糖尿病PRP的生长因子和外体水平.
主要方法:
- 人体皮肤纤维细胞与1型糖尿病患者和对照组的PRP进行培养.
- 评估了细胞代谢活动,活性氧物种 (ROS) 生产,迁移和扩散.
- 测量了PRP和培养基中的生长因子和外体度.
主要成果:
- 来自1型糖尿病患者的PRP对纤维细胞的增殖效果较低.
- 糖尿病患者的PRP表现出促氧化性质和纤维细胞毒性增加 (活力降低,死亡率更高).
- 纤维细胞迁移没有明显受损,但糖尿病患者的PRP显示增长因子分泌的刺激减少.
结论:
- 从1型糖尿病患者中获得的PRP在体外减少了再生能力.
- 糖尿病PRP对纤维细胞代谢活动和活力产生负面影响,这表明治疗潜力发生了变化.
- 老年糖尿病患者的年龄可能会进一步改变这些影响,因此需要特别考虑.
更多相关视频
07:51Effects of Allogeneic Platelet-Rich Plasma PRP on the Healing Process of Sectioned Achilles Tendons of Rats: A Methodological Description
Published on: March 19, 2018
9.2K
06:36PRP as a New Approach to Prevent Infection: Preparation and In vitro Antimicrobial Properties of PRP
Published on: April 9, 2013
21.2K
相关概念视频
Formation of the Platelet Plug
3.3K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
3.3K
iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K
